Global Antibody Market Size By Product Type(Monoclonal antibodies, Polyclonal antibodies), By Disease Indication(cardiovascular diseases, CNS disorders, cancer), By End User(hospitals, diagnostic laboratories), By Geographic Scope And Forecast

 Antibody Market Size And Forecast

Antibody Market size was valued at USD 125 Billion in 2021 and is projected to reach USD 330 Billion by 2030, growing at a CAGR of 11.25 % from 2023 to 2030.

The potential for the antibodies market to grow will be stimulated by a strong focus on the discovery and development of novel antibodies therapeutics to provide highly targeted therapy for complex and severe diseases. Players in the business will primarily benefit from government backing and regulatory permissions to increase the antibodies market. The Global Antibody Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

What is Antibody?

Antibody, also known as immunoglobulin, is a protein created by the immune system in reaction to the presence of an antigen, a foreign substance. Antibodies identify antigens and attach them to them in order to eliminate them from the body. The body classifies a wide variety of chemicals as antigens, including noxious substances like insect venom and pathogenic organisms. The immune system can identify foreign substances when they enter the body because the antigen’s surface molecules are different from those found in the body. The immune system uses a number of methods, including one of the most crucial ones—antibody production—to get rid of the intruder. Specialized white blood cells called B lymphocytes create antibodies (or B cells). A clone is a collection of identical cells that is created when a B cell divides and matures in response to an antigen binding to the B cell surface. Millions of antibodies are secreted into the lymphatic and circulation by mature B cells, also known as plasma cells. The same antigens that caused the immune response are attacked and neutralized by antibodies as they travel through the body. Antibodies attach to antigens and then assault them.

Global Antibody Market Overview

Cancer, autoimmune illnesses, and many types of neurological problems can all be treated with antibodies. Immunoglobulins (IG), a specific class of antibodies, are used to prevent disorders brought on by the vaccine virus and lower respiratory tract infections. The need for antibodies will increase due to an increase in viral infection cases.

The factor driving the market is the sudden rise in the prevalence of chronic infectious and uncommon disorders. For instance, the World Health Organization estimates that approximately 10 million people worldwide will die from cancer in 2020. This has resulted in a third of cancer-related fatalities in the same year. As a result, the market for antibodies will rise due to the rising demand for efficient and economical cancer treatments.

The COVID-19 virus outbreak has had a favorable impact on the expansion of the antibodies industry. Effective treatments are required due to the sudden increase in individuals with COVID-19 and the mortality risk associated with the illness. Additionally, due to its potential to reduce disease burden, numerous industry participants are consistently engaged in the development of novel antibodies for COVID-19 virus prevention and treatment.

Global Antibody MarketSegmentation Analysis

The global antibody market is classified into Product Type, Disease Indication, End User, and Geographic Scope

Antibody Market by Product Type

• Monoclonal antibodies• Polyclonal antibodies• Antibody-drug complexes (ADCs)

The global Antibody market is basically classified into Monoclonal antibodies, Polyclonal antibodies, and Antibody-drug complexes (ADCs). Monoclonal antibodies dominate the global market. Monoclonal antibodies are within the category of proteins that can bind to particular cell types. These are identical immunoglobulins that identify a specific binding site on the antigen and were produced by a single B-cell. MAbs are being utilized more frequently for therapeutic and diagnostic purposes for various diseases because of their selectivity to distinct epitopes. Monoclonal antibodies are widely used today to treat a variety of illnesses, including cancer, cardiovascular disease, autoimmune disorders, blood disorders, and infectious diseases.

Antibody Market by Disease Indication

• Cardiovascular diseases• CNS disorders• Cancer• Autoimmune Disorders• Infectious Diseases• Others

On the basis of application, the Antibody market is bifurcated into cardiovascular diseases, CNS disorders, cancer, autoimmune disorders, infectious diseases, and others. On the global market, the cancer category holds the dominant position. The prevalence of the cancer disease, the increase in antibody research, and the expansion of healthcare facilities are the factors driving the growth of these markets.

Antibody Market by End User

• Hospitals• Diagnostic Laboratories• Research Institutes

On the basis of application, the antibody market is bifurcated into hospitals, diagnostic laboratories, and research institutes. An increase in the R&D activities on the production of the antibiotics along with the large number of clinical trials to develop new drugs for cardiovascular diseases, cancer, and other infectious diseases.

Antibody Market by Geography

• North America• Europe• Asia Pacific• Latin America• Middle-East and Africa

Based on regional analysis, the global Antibody market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Due to an increase in government efforts, increased funding for overall R&D of monoclonal antibody therapy, and an increase in the number of product approvals, Asia-Pacific offers attractive potential for key players operating in the antibodies market. Additionally, the availability of modern healthcare systems, continual advancements in antibodies, and a major increase in demand for advanced healthcare facilities also contribute to the market’s expansion.

Key Players

The major players in the Antibody market are Novartis AG, Bio-Rad Laboratories, Inc., Abott, Eli Lilly and Co., Pfizer Inc., AbbVie Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Biogen Inc., Crown Bioscience, Inc., Sanofi SA and Others.

The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In June 2021, Amgen and Kyowa Kirin Co. Ltd. signed into a contract to develop and distribute KHK4083, a completely human monoclonal antibody for the treatment of atopic dermatitis. These collaborations have aided the company’s growth.

• In May 2021, Roche India stated that the Central Drugs Standards Control Organization had granted their antibody cocktail an Emergency Use Authorization (EUA) (CDSCO). The corporation has been able to increase product accessibility in the nation thanks to this authorization.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.